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trends of prescription medication use were analysed. Since the sample size
was insufficient for reliable statistical analysis, a descriptive report of the pre-
scription drug utilisation patterns was created.
RESULTS:  MATERNAL MEDICATION
Out of 400, there were 90 (22.5%) women taking prescription medications
and 44 (11%) on no medications. There were 266 (66.5%) women on folic
acid and/or vitamin D alone. The live birth rate of the women on prescription
medications was 32.2% (n¼29). The live birth rate of the 44 women on no
medications was 29.5% (n¼13). The live birth rate of the women on folic
acid and/or vitamin D was 33.5% (n¼89).
There were a total of 60 different medications at an average of 1.4 per pa-
tient.
The most common medications were asthma medications (n¼22), levo-
thyroxine (n¼12), selective serotonin re-uptake inhibitors (SSRIs) (n¼10),
ferrous sulphate (n¼8), and diabetic medications (n¼7).
Food and Drug Administration categories: 1 medication and 12 prescrip-
tions at Category A. Category B: 20 medications and 29 prescriptions. Cate-
gory C: 25 medications and 62 prescriptions. Category D: 6 medications and
6 prescriptions. Category X: 1 medications and 1 prescription.
 PATERNAL MEDICATION
Out of 400, 88 male partners were on prescription medication (22%). The
live birth rate for those on medication was 30.7% (n¼27) compared to those
not on medication 33.0% (n¼103).
 SMOKING
Female: out of 376, 19 smoked (5.1%) averaging 6.1 per day (StandardDe-
viation (SD) 4.47). Live birth rate in the smokers was 21.1% (n¼4) compared
to non-smokers, 30.5% (n¼109).
Male: Out of 316 male patients, 44 smoked (13.9%) averaging 8.3 per day
(SD 6.9). The live birth rate in smokers was 27.3% (n¼12) compared to
32.0% (n¼101).
 ALCOHOL
Female: out of 275, 178 drank alcohol (47.5%), averaging 5.8 units per
week (SD 5.6). The live birth rate in drinkers was 28.1% (n¼50) compared
to 36.5% (n¼72)
Male: out of 375, 240 drank alcohol (64%), averaging 9.1 units per week
(SD 8.2). The live birth rate in drinkers was 33.8% (n¼81) compared to
30.4% (n¼41).
CONCLUSIONS: The study found that a large number of women are pre-
scribed category C, D or X drugs when attempting ART. The effect these
drugs have on the success of ART is unclear. More information is required
in order to expand these results and help counsel couples on prescription
drug use, smoking and alcohol consumption.
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OBJECTIVE: To evaluate the association between dietary cadmium intake
(D-Cd) and fecundability. Diet is one of themain sources of cadmium, and D-
Cd is often used as indicator of cadmium exposure, particularly in non-smok-
ing populations. In a previous preconception cohort study of 501 couples,1
high female cadmium concentrations measured in whole blood were associ-
ated with reduced fecundability.
DESIGN: Prospective cohort study (2013-2018).
MATERIALS ANDMETHODS: Pregnancy Online Study (PRESTO) is a
North American prospective preconception cohort of pregnancy planners. At
baseline, female participants aged 21-45 years completed a web-based ques-
tionnaire on demographic, lifestyle, medical and reproductive factors. Ten
days after enrollment, participants completed the National Cancer Institute
Dietary History Questionnaire II, a validated food frequency questionnaire
(FFQ) of average intake during the previous year. D-Cd (mg/day) was esti-
mated by combining FFQ responses with US Food and Drug Administration
data on food cadmium content. Participants were then followed for up to 12
months or until reported pregnancy, whichever came first. The analysis
included 4,768 women attempting to conceive for %6 cycles at study entryFERTILITY & STERILITYand not using fertility treatment. We used a proportional probabilities regres-
sion model to estimate fecundability ratios (FR) and 95% confidence inter-
vals (CI), adjusted for age, body mass index (BMI), smoking history,
parity, physical activity, last method of contraception, daily use of multivita-
mins, race/ethnicity, education, income, geographic region, and the 2010
healthy eating index score. We used the nutrient residual approach to adjust
for energy intake.
RESULTS: Median D-Cd was 8.0 mg/day (interquartile range: 7.0-9.1 mg/
day). The top 5 contributors to D-Cd were nuts and seeds; fried potatoes; dark
green lettuce; cooked greens; and white potatoes. Compared with an average
D-Cd of<6.8 mg/day, FRs for D-Cd quintiles of 6.8-7.6, 7.7-8.4, 8.5-9.5, and
R9.6 mg/day were 1.03 (CI: 0.92-1.14), 1.07 (CI: 0.96-1.18), 1.07 (CI: 0.96-
1.19), and 1.08 (0.97-1.20), respectively. Results were not appreciably
different among never smokers with no current passive smoke exposure,
for whom cadmium exposure from other sources (e.g., cigarettes) would
be lower (respective FRs: 1.02, 1.05, 1.06 and 1.02). Results did not differ
materially by age (<30 vs.R30 years), BMI (<30 vs.R30 kg/m2), total fi-
ber intake (<25 vs.R25 g/day), geographic region of residence (West, Mid-
west, Northeast, South, Canada), or attempt time at study entry (<3 vs. R3
cycles).
CONCLUSIONS: Dietary intake of cadmium was not appreciably associ-
ated with fecundability, though exposure misclassification and confounding
could explain the null results.
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OBJECTIVE: To determine whether reproductive health outcomes are
associated with changes in menstrual function among women within the
Michigan Polybrominated Biphenyl (PBB) Registry.
DESIGN: Cross-sectional survey of women in theMichigan PBBRegistry.
MATERIALS AND METHODS: In 1973, accidental contamination of
livestock feed with PBB led to the Michigan Health Department establishing
a registry of highly exposed individuals who have been followed for >40
years. Women who were not pregnant, breastfeeding, using hormonal medi-
cations, developmentally disabled, diagnosed with cancer, amenorrheic 3
three months, or with prior hysterectomy were recruited into a menstrual
function study. 176 women completed a reproductive health survey, obtained
daily morning urine samples throughout 4 menstrual cycles, and completed 6
months of daily menstrual cycle diaries. The morning urine samples were
analyzed for Estrone-3-glucuronide (E13G), Pregnanediol-3-glucuronide
(Pd3G), mid-cycle creatinine, and day of luteal transition (DLT). We used
a nested mixed linear model to quantify the accuracy of menstrual cycle
data and to test for association between endometriosis, infertility, and urinary
hormone metabolites.
RESULTS:Women’s self-reported cycle and bleed length correlated accu-
rately with their actual cycle length (p¼0.002) and bleed length (p¼2.31E-
13) from urinary metabolite data. Women with self-reported endometriosis
were noted to have higher preovulatory E13G (p¼0.001), mid-luteal E13G
(p¼0.0006), and overall luteal phase E13G (p¼0.033) levels. Women with
self-reported infertility were noted to have higher mid-luteal E13G
(p¼0.019) and overall luteal phase E13G (p¼0.008) levels.
CONCLUSIONS: Women with self-reported diagnoses of endometriosis
and infertility showed statistically significant changes in their menstrual
function urinary metabolites. Additionally, this study found that the self-e341
